↓ Skip to main content

The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors

Overview of attention for article published in Frontiers in immunology, August 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors
Published in
Frontiers in immunology, August 2018
DOI 10.3389/fimmu.2018.01914
Pubmed ID
Authors

Ana C. R. Moreno, Bruna F. M. M. Porchia, Roberta L. Pagni, Patrícia da Cruz Souza, Rafael Pegoraro, Karine B. Rodrigues, Tácita B. Barros, Luana R. de Melo Moraes Aps, Eliseu F. de Araújo, Vera L. G. Calich, Luís C. de Souza Ferreira

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 6 13%
Student > Bachelor 5 11%
Student > Master 5 11%
Professor 3 6%
Researcher 3 6%
Other 5 11%
Unknown 20 43%
Readers by discipline Count As %
Immunology and Microbiology 7 15%
Medicine and Dentistry 6 13%
Biochemistry, Genetics and Molecular Biology 5 11%
Agricultural and Biological Sciences 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Other 2 4%
Unknown 19 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2022.
All research outputs
#14,898,569
of 25,838,141 outputs
Outputs from Frontiers in immunology
#12,680
of 32,474 outputs
Outputs of similar age
#171,260
of 343,563 outputs
Outputs of similar age from Frontiers in immunology
#303
of 631 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,474 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,563 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 631 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.